CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...